Results 41 to 50 of about 116,042 (299)

KAJIAN MOLEKULER RESISTENSI Candida albicans TERHADAP ANTIFUNGI

open access: yesJurnal Farmasi Sains dan Komunitas, 2014
: Candida albicans is one of the species Candida which mostly cause infection in human. Antifungal agent azole, polyene, echinocandin, and flucytosine are commonly used for Candida albicans infection treatment.
Damiana Sapta Candrasari
doaj   +1 more source

Mechanisms of Antifungal Drug Resistance [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2014
Antifungal therapy is a central component of patient management for acute and chronic mycoses. Yet, treatment choices are restricted because of the sparse number of antifungal drug classes. Clinical management of fungal diseases is further compromised by the emergence of antifungal drug resistance, which eliminates available drug classes as treatment ...
Cowen Leah E   +4 more
openaire   +3 more sources

Antifungal Resistance and New Strategies to Control Fungal Infections

open access: yesInternational Journal of Microbiology, 2012
Despite improvement of antifungal therapies over the last 30 years, the phenomenon of antifungal resistance is still of major concern in clinical practice.
Patrick Vandeputte   +2 more
doaj   +1 more source

Exploring hidden dimensions of soil fungal biodiversity: A simple technique to detect soil fungi resistant to antifungal compounds

open access: yes, 2010
Soils are known to be ultimate and complex reservoirs of microbial diversity. The complex dimensions of bacterial and fungal diversity in tropical soils and microbial community dynamics are underexplored.
Sonashia Velho-Pereira   +1 more
core   +1 more source

Species Distribution and in Vitro Antifungal Susceptibility of Oral Yeast Isolates from Tanzanian HIV-Infected Patients With Primary and Recurrent Oropharyngeal Candidiasis. [PDF]

open access: yes, 2008
\ud In Tanzania, little is known on the species distribution and antifungal susceptibility profiles of yeast isolates from HIV-infected patients with primary and recurrent oropharyngeal candidiasis.
Rijs Antonius JMM   +51 more
core   +1 more source

Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America

open access: yesJournal of Fungi, 2021
In different regions worldwide, there exists an intra-and inter-regional variability in the rates of resistance to antifungal agents in Candida glabrata, highlighting the importance of understanding the epidemiology and antifungal susceptibility profiles
Erick Martínez-Herrera   +6 more
doaj   +1 more source

Worldwide emergence of resistance to antifungal drugs challenges human health and food security [PDF]

open access: yes, 2018
The recent rate of emergence of pathogenic fungi that are resistant to the limited number of commonly used antifungal agents is unprecedented. The azoles, for example, are used not only for human and animal health care and crop protection but also in ...
Fisher, Matthew C   +14 more
core   +1 more source

Antifungal resistance: current trends and future strategies to combat

open access: yes, 2017
Nathan P Wiederhold Department of Pathology and Laboratory Medicine, Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA Abstract: Antifungal resistance represents a major clinical challenge to ...
Nathan Wiederhold, Wiederhold NP
core   +1 more source

Use of volatile fingerprints for rapid screening of antifungal agents for efficacy against dermatophyte Trichophyton species [PDF]

open access: yes, 2010
The potential of using an electronic nose (E-nose) as a rapid technique for screening the responses of dermatophytes to antifungal agents was studied.
Adriaans, B   +9 more
core   +1 more source

Antifungal drug resistance mechanisms

open access: yesExpert Review of Anti-infective Therapy, 2009
Antifungal resistance is a prominent feature in the management of invasive mycoses, with important implications for morbidity and mortality. Microbiological resistance, the most common cause of refractory infection, is associated with a fungal pathogen for which an antifungal MIC is higher than average or within the range designated as the resistant ...
Peman, Javier   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy